The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in the European Union (EU) for the expanded use of Byetta (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos® (pioglitazone)...
Insulet Corporation, the company behind OmniPod Insulin Management System, announced it has signed a worldwide agreement with LifeScan, Inc. to integrate LifeScan's OneTouch blood glucose monitoring technology into...
Finnish diabetes technology company Mendor has announced an international partnership distribution agreement with a leading pharmaceutical company in the diabetes field, Merck Serono, covering the United Kingdom diabetes market.
Mendor’s first product, a blood glucose meter...
The newly approved type 2 diabetes drug Bydureon, made by Amylin Pharmaceuticals and Alkermes plc, is now available by prescription in U.S. pharmacies.
Bydureon is the first and only once-weekly treatment for type 2 diabetes. It was approved by the US FDA ...
British based Cellnovo announced the commercial launch of the its new mobile-connected diabetes management system, and the start of the largest usability trial ever to investigate insulin pump technology for patients with type 1 diabetes. The trial will also be the first in which all clinical data is captured remotely, in real-time, using the mobile data connectivity of the Cellnovo system...
We rarely eat anything sweet, and we don't usually publish recipes with sweeteners of any sort. But sometimes you have to make exceptions. Valentine's Day is one of those times.
If you're going to celebrate Valentine's Day with chocolate, there are ways to do it that shouldn't make your blood sugar soar.
The FDA has approved Merck's (MSD) new type 2 diabetes medication, JANUMET(R) XR (sitagliptin and metformin hydrochloride (HCl) extended-release) The new treatment combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin...
Continuous glucose monitoring systems maker DexCom, Inc. and Tandem, the developer of first ever touch-screen insulin pump, announced that they have signed a Development and Commercialization Agreement to integrate a future generation of DexCom's...
The FDA has approved Eli Lilly and Boehringer Ingelheim's new type 2 diabetes treatment Jentadueto (linagliptin/metformin hydrochloride), which combines DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta™ (linagliptin) tablets), and metformin in a single tablet...
Amylin Pharmaceuticals, Inc. and Alkermes plc received FDA approval for Bydureon, a next generation once-weekly treatment for type 2 diabetes. The drug which received EU approval in June was turned down by the FDA twice during 2010, requesting further testing be conducted...